SE9003395L - Anvaendning av inositoltrifosfat foer framstaellning av laekemedel - Google Patents

Anvaendning av inositoltrifosfat foer framstaellning av laekemedel

Info

Publication number
SE9003395L
SE9003395L SE9003395A SE9003395A SE9003395L SE 9003395 L SE9003395 L SE 9003395L SE 9003395 A SE9003395 A SE 9003395A SE 9003395 A SE9003395 A SE 9003395A SE 9003395 L SE9003395 L SE 9003395L
Authority
SE
Sweden
Prior art keywords
preparation
medicinal products
inositol triphosphate
inositol
triphosphate
Prior art date
Application number
SE9003395A
Other languages
Unknown language ( )
English (en)
Other versions
SE9003395D0 (sv
Inventor
M Siren
Original Assignee
Perstorp Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Perstorp Ab filed Critical Perstorp Ab
Publication of SE9003395D0 publication Critical patent/SE9003395D0/sv
Publication of SE9003395L publication Critical patent/SE9003395L/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • External Artificial Organs (AREA)
SE9003395A 1988-09-15 1990-10-24 Anvaendning av inositoltrifosfat foer framstaellning av laekemedel SE9003395L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8803248A SE464059C (sv) 1988-09-15 1988-09-15 Användning av inositoltrifosfat för framställning av läkemedel

Publications (2)

Publication Number Publication Date
SE9003395D0 SE9003395D0 (sv) 1990-10-24
SE9003395L true SE9003395L (sv) 1992-04-25

Family

ID=20373330

Family Applications (2)

Application Number Title Priority Date Filing Date
SE8803248A SE464059C (sv) 1988-09-15 1988-09-15 Användning av inositoltrifosfat för framställning av läkemedel
SE9003395A SE9003395L (sv) 1988-09-15 1990-10-24 Anvaendning av inositoltrifosfat foer framstaellning av laekemedel

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE8803248A SE464059C (sv) 1988-09-15 1988-09-15 Användning av inositoltrifosfat för framställning av läkemedel

Country Status (8)

Country Link
EP (5) EP0359260B1 (sv)
JP (5) JPH02191218A (sv)
AT (5) ATE104855T1 (sv)
DE (5) DE68914922T2 (sv)
ES (5) ES2054965T3 (sv)
GB (5) GB2223167B (sv)
GR (4) GR3005448T3 (sv)
SE (2) SE464059C (sv)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5330979A (en) * 1984-10-23 1994-07-19 Perstorp Ab Method of treating renal disorders with inositoltriphosphate
US5427956A (en) * 1989-03-08 1995-06-27 The University Of Virginia Patent Foundation Quantitative analysis for diabetic condition predictor
DK0465508T3 (da) * 1989-03-08 2000-08-07 Univ Virginia Diætsupplement til insulinresistente diabetikere
US5428066A (en) * 1989-03-08 1995-06-27 Larner; Joseph Method of reducing elevated blood sugar in humans
US5750348A (en) * 1989-03-08 1998-05-12 The University Of Virginia Patents Foundation Method for detecting insulin resistance
SE9002278L (sv) * 1990-06-28 1991-12-29 Perstorp Ab Anvaendning av inositoltrisfosfat foer framstaellning av ett laekemedel
SE467340B (sv) * 1990-07-04 1992-07-06 Perstorp Ab Anvaendning av inositolmonofosfat foer framstaellning av ett laekemedel effektivt som en neuropeptid y-(npy-)antagonist
JP2750239B2 (ja) * 1991-08-14 1998-05-13 三共株式会社 アデノホスチンａまたはｂならびにその製法
SE503122C2 (sv) * 1993-11-22 1996-03-25 Perstorp Ab Användning av en inositoltrisfosfatester för behandling av inflammatoriska tillstånd
SE9600194D0 (sv) * 1996-01-19 1996-01-19 Perstorp Ab A new chemical compound
US5880098A (en) * 1996-04-12 1999-03-09 Pharmacia & Upjohn Aktiebolag Therapeutic treatment
SE9601396D0 (sv) * 1996-04-12 1996-04-12 Dieter Haeussinger New therapeutic treatment 2
SE9602463D0 (sv) * 1996-06-24 1996-06-24 Perstorp Ab The use of growth factor modulating compounds
US5998485A (en) * 1997-06-16 1999-12-07 Cedars-Sinai Medical Center Method for modulating immune response with inositol
US5906979A (en) * 1998-01-27 1999-05-25 Insmed Pharmaceuticals, Inc. Compositions and methods for treating metabolic diseases characterized by hyperandrogenism and/or anovulation and/or infertility
US6486127B1 (en) 2001-05-23 2002-11-26 Insmed, Incorporated Compositions comprising D-chiro inositol and lipid lowering compounds and methods of treatment thereof
KR100653557B1 (ko) * 2001-10-06 2006-12-05 아미코젠주식회사 카이로 이노시톨 또는 피니톨의 백내장 예방치료제로서의용도와 그 조성물
CN111246852A (zh) * 2017-10-26 2020-06-05 大塚制药株式会社 含有磷酸肌醇的组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE465951B (sv) * 1984-10-23 1991-11-25 Perstorp Ab Isomer av inositoltrifosfat foeretraedesvis i saltform foer anvaendning som terapeutiskt eller profylaktiskt medel samt kompositioner daerav
SE465305B (sv) * 1986-04-16 1991-08-26 Perstorp Ab Anvaendning av inositolfosfat foer framstaellning av ett laekemedel
US4735902A (en) * 1984-10-23 1988-04-05 Matti Siren Stabilized composition containing inositoltriphosphate

Also Published As

Publication number Publication date
EP0359259A3 (en) 1990-10-03
ATE84719T1 (de) 1993-02-15
ES2055772T3 (es) 1994-09-01
DE68914922T2 (de) 1994-09-01
GR3015764T3 (en) 1995-07-31
JPH02191220A (ja) 1990-07-27
JP2859318B2 (ja) 1999-02-17
GB2223403B (en) 1992-02-26
DE68902526D1 (de) 1992-09-24
DE68904507D1 (de) 1993-03-04
JP2547257B2 (ja) 1996-10-23
GB2223404B (en) 1992-04-08
ES2054965T3 (es) 1994-08-16
SE9003395D0 (sv) 1990-10-24
GB8920806D0 (en) 1989-11-01
EP0359260A3 (en) 1990-10-03
ATE88347T1 (de) 1993-05-15
GR3007686T3 (sv) 1993-08-31
EP0359260B1 (en) 1993-04-21
GB8920805D0 (en) 1989-11-01
GB2223404A (en) 1990-04-11
EP0359256B1 (en) 1993-01-20
GR3005448T3 (sv) 1993-05-24
GB8920811D0 (en) 1989-11-01
GB2223403A (en) 1990-04-11
EP0359257A3 (en) 1990-10-03
GB2223168A (en) 1990-04-04
GB8920804D0 (en) 1989-11-01
EP0359260A2 (en) 1990-03-21
DE68922165D1 (de) 1995-05-18
ES2073419T3 (es) 1995-08-16
SE464059B (sv) 1991-03-04
GB2223169A (en) 1990-04-04
EP0359257A2 (en) 1990-03-21
DE68922165T2 (de) 1995-09-14
DE68906106T2 (de) 1993-10-21
JPH02191219A (ja) 1990-07-27
GB2223167A (en) 1990-04-04
ATE104855T1 (de) 1994-05-15
SE464059C (sv) 1996-12-04
DE68904507T2 (de) 1993-06-09
JPH02191218A (ja) 1990-07-27
ES2045319T3 (es) 1994-01-16
DE68914922D1 (de) 1994-06-01
EP0359258B1 (en) 1994-04-27
EP0359259B1 (en) 1992-08-19
JP3058334B2 (ja) 2000-07-04
JPH02191221A (ja) 1990-07-27
EP0359259A2 (en) 1990-03-21
EP0359258A2 (en) 1990-03-21
DE68906106D1 (de) 1993-05-27
GB8920807D0 (en) 1989-11-01
DE68902526T2 (de) 1993-03-11
GB2223168B (en) 1992-08-12
ATE120958T1 (de) 1995-04-15
ATE79542T1 (de) 1992-09-15
GB2223167B (en) 1992-02-26
EP0359256A3 (en) 1990-10-10
JPH02191217A (ja) 1990-07-27
JP2859319B2 (ja) 1999-02-17
GB2223169B (en) 1992-04-08
EP0359257B1 (en) 1995-04-12
EP0359256A2 (en) 1990-03-21
SE8803248L (sv) 1990-03-16
SE8803248D0 (sv) 1988-09-15
EP0359258A3 (en) 1990-10-03
GR3006825T3 (sv) 1993-06-30
ES2043998T3 (es) 1994-01-01

Similar Documents

Publication Publication Date Title
SE8803248L (sv) Anvaendning av inositoltrifosfat foer framstaellning av laekemedel
ES2024010B3 (es) Unidad de dosis farmaceutica.
ES1006927Y (es) Zapato para pacientes que han sufrido operacion quirurgica en la parte delantera del pie.
ATE75613T1 (de) 17-benzylspartein-derivate enthaltende positiv inotrop wirksame pharmazeutische zubereitungen.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 9003395-2

Effective date: 19930403

Format of ref document f/p: F